ENTRY       D00254                      Drug
NAME        Carmustine (JAN/USP/INN);
            Bicnu (TN);
            Gliadel (TN)
PRODUCT     BICNU (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            CARMUSTINE (Accord Healthcare)
            GLIADEL (Arbor Pharmaceuticals)
  GENERIC   CARMUSTINE (Amneal Pharmaceuticals LLC)
            CARMUSTINE (Athenex Pharmaceutical Division)
            CARMUSTINE (Dr. Reddy's Laboratories)
            CARMUSTINE (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            CARMUSTINE (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals)
            CARMUSTINE (Meitheal Pharmaceuticals)
            CARMUSTINE (Navinta LLC)
            CARMUSTINE (STI Pharma LLC)
            CARMUSTINE (Sandoz)
            CARMUSTINE (Zydus Pharmaceuticals USA)
FORMULA     C5H9Cl2N3O2
EXACT_MASS  213.0072
MOL_WEIGHT  214.0499
CLASS       Antineoplastic
             DG01677  Alkylating agent
              DG01724  Nitrosourea
REMARK      Same as: C06873
            Therapeutic category: 4219
            ATC code: L01AD01
            Product: D00254<JP/US>
EFFICACY    Antineoplastic, Alkylating agent
  DISEASE   Glioma [DS:H00042]
            Glioblastoma [DS:H00042]
            Medulloblastoma [DS:H01667]
            Astrocytoma [DS:H00042]
            Ependymoma [DS:H00042]
            Multiple myeloma [DS:H00010]
            Hodgkin's lymphoma [DS:H00007]
            Non-Hodgkin's lymphomas [DS:H02418]
TARGET      DNA
INTERACTION  
STR_MAP     map07040  Antineoplastics - alkylating agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
              L01 ANTINEOPLASTIC AGENTS
               L01A ALKYLATING AGENTS
                L01AD Nitrosoureas
                 L01AD01 Carmustine
                  D00254  Carmustine (JAN/USP/INN) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Antineoplastics
              Alkylating Agents
               Carmustine
                D00254  Carmustine (JAN/USP/INN)
            Therapeutic category of drugs in Japan [BR:br08301]
             4  Agents affecting cellular function
              42  Antineoplastics
               421  Alkylating agents
                4219  Others
                 D00254  Carmustine (JAN/USP/INN)
            Drug groups [BR:br08330]
             Antineoplastic
              DG01677  Alkylating agent
               DG01724  Nitrosourea
                D00254  Carmustine
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D00254
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D00254
DBLINKS     CAS: 154-93-8
            PubChem: 7847320
            ChEBI: 3423
            LigandBox: D00254
            NIKKAJI: J2.968H
ATOM        12
            1   N1c N    23.3800  -16.1000
            2   C5a C    22.1900  -15.4700
            3   C1b C    24.5700  -15.4700
            4   N2b N    23.3800  -17.5000
            5   N1b N    20.9300  -16.1000
            6   O5a O    22.1900  -14.0700
            7   C1b C    25.8300  -16.1000
            8   O3a O    22.1900  -18.2700
            9   C1b C    19.7400  -15.4700
            10  X   Cl   27.0200  -15.4700
            11  C1b C    18.4800  -16.1000
            12  X   Cl   17.2900  -15.4700
BOND        11
            1     1   2 1
            2     1   3 1
            3     1   4 1
            4     2   5 1
            5     2   6 2
            6     3   7 1
            7     4   8 2
            8     5   9 1
            9     7  10 1
            10    9  11 1
            11   11  12 1
///
